We have previously demonstrated that site-specific insertion, deletion or substitution of one or two nucleotides in mouse embryonic stem cells (ES cells) by single-stranded deoxyribo-oligonucleotides is several hundred-fold suppressed by DNA mismatch repair (MMR) activity. Here, we have investigated whether compound mismatches and larger insertions escape detection by the MMR machinery and can be effectively introduced in MMR-proficient cells. We identified several compound mismatches that escaped detection by the MMR machinery to some extent, but could not define general rules predicting the efficacy of complex base-pair substitutions. In contrast, we found that fournucleotide insertions were largely subject to suppression by the MSH2/MSH3 branch of MMR and could be effectively introduced in Msh3-deficient cells. As these cells have no overt mutator phenotype and Msh3-deficient mice do not develop cancer, Msh3-deficient ES cells can be used for oligonucleotide-mediated gene disruption. As an example, we present disruption of the Fanconi anemia gene Fancf. Gene Therapy (2006) 13, 686-694.
Introduction
Gene targeting in mouse embryonic stem cells (ES cells) by homologous recombination is widely used to generate mouse lines carrying constitutive or conditional knockout alleles (http://www.informatics.jax.org). However, the functional annotation of the mouse genome would greatly benefit from high-throughput generation of mutant alleles. One approach to accelerate the generation of mouse mutants may be oligonucleotide-mediated gene modification. Already 15 years ago, two reports have described the successful modification of chromosomally located genes in Saccharomyces cerevisiae or an episomally located gene in human cells by singlestranded DNA oligonucleotides. 1, 2 Since then, oligonucleotide-mediated modification of chromosomally and episomally located genes has been extensively studied in Escherichia coli, S. cerevisiae and mammalian cells using a variety of different oligonucleotide designs including single-stranded DNA oligonucleotides, doublestranded RNA-DNA hybrids and single-stranded DNA oligonucleotides that contain phosphorothioate linkages or 2 0 -O-methyluracil residues to improve their intracellular stability. [3] [4] [5] [6] These studies have firmly established the feasibility of oligonucleotide-mediated gene modification and identified a number of parameters affecting its efficacy. In yeast and mammalian cells, the efficiency of chemically modified DNA oligonucleotides was enhanced by transcriptional activity of the target gene and antisense oligonucleotides (complementary to the non-transcribed strand) appeared to be more effective than sense oligonucleotides. 7, 8 In contrast, in E. coli, transcription or the direction of transcription did not play a role in Redb-assisted gene modification by non-chemically modified single-stranded DNA oligonucleotides. 3 Instead, replication appeared to be a major determinant, oligonucleotides corresponding to the lagging strand being more effective than leading strand oligonucleotides. 3, 9, 10 Also in mammalian cells, a modestly increased efficiency of lagging strand over leading strand oligonucleotides was observed and the efficacy of oligonucleotide-mediated gene modification was dependent on the phase of the cell cycle, the highest frequencies being found when oligonucleotides were delivered to cells immediately after release of a G 1 /S block. 11, 12 Furthermore, the efficacy could be improved by slowing down progression of replication forks again suggesting that also in mammalian cells at least one mechanism of oligonucleotide-mediated gene modification involves replication of DNA. 13, 14 We have previously identified another parameter affecting the frequency of oligonucleotide-mediated gene modification: DNA mismatch repair (MMR). We found that single-stranded synthetic oligonucleotide sequences consisting of 20-60 non-chemically modified deoxyribonucleotides can be used to site-specifically delete, insert or substitute one or a few base pairs in the genome of murine ES cells. 15 However, 'oligo targeting' (as we will further refer to this procedure), was only effective in cells defective for the central MMR gene Msh2. In MMRdeficient cells, the frequency of gene modification obtained was 2-4/10 5 cells that had survived exposure to the oligonucleotides. In contrast, in wild-type cells, the presence of MSH2 protein suppressed oligonucleotidemediated gene correction several hundred-fold. Similarly, enhancement of oligo targeting was found in the E. coli/Redb system upon inactivation of the mutS,L,H MMR system. 16 Although the mechanism of transfer of genetic information from the oligonucleotide to the genome is elusive, annealing of the single-stranded oligonucleotide to its chromosomal complement seems an imperative step. Owing to the presence of mismatches, MMR may destabilize this heteroduplex, thus preventing the transfer of genetic information.
MMR normally acts to restore mismatched nucleotides in DNA arising by erroneous replication or occurring in heteroduplex regions formed at initial stages of recombination between homologous but non-identical DNA molecules. [17] [18] [19] DNA mismatches can be recognized by two heterodimeric protein complexes: MSH2/MSH6 and MSH2/MSH3, which have specific and overlapping mismatch recognition capacities. The MSH2/6 dimer has been suggested to recognize single base-base mismatches and small loops of one to three unpaired nucleotides, whereas the MSH2/3 heterodimer is believed to predominantly recognize loops of two to five nucleotides. 20, 21 The requirement for MMR deficiency imposes a severe restriction to the applicability of oligo targeting for the generation of mutant cell lines and mouse strains. Owing to the mutator phenotype of MMR-deficient cells, numerous inadvertent mutations may accumulate on top of the desired one, which could interfere with the viability and phenotype of cells. In an attempt to broaden the applicability of oligo targeting, we explored the possibility that specific alterations escape detection by the MMR machinery and can be effectively introduced in MMR-proficient cells. Furthermore, we investigated whether four-nucleotide insertions that are expected to be predominantly recognized by MSH2/3 activity can be effectively introduced in Msh3-deficient cells.
Results

Oligonucleotide-directed base substitution
We have previously presented an oligo targeting reporter system in mouse ES cells consisting of neomycin resistance (neo) genes that were rendered inactive by either a substitution in the start codon ( Figure 1a : target 2, AAG) or a 2 bp insertion in the open-reading frame immediately downstream of the start codon (Figure 2a : target 1, extra GT). 15 Single copies of the recombination reporters have been inserted by gene targeting into a specific genomic locus (Rosa 26) in wild-type and Msh2-deficient ES cells. We found that correction of the neo open-reading frames, as monitored by the appearance of G418-resistant cells, could be achieved by single-stranded DNA oligonucleotides of 735 residues. 15 However, this type of gene correction was strongly suppressed by DNA MMR. Thus, in Msh2-deficient cells, substitution or insertion of a single nucleotide occurred at a frequency of 4.7 and 7.4/10 5 cells, respectively (Figures 1b and 2b ).
In contrast, in wild-type cells, the presence of MSH2 suppressed single-nucleotide substitution more than 150-fold ( Figure 1b ) and insertion at least 700-fold ( Figure 2b ). We next explored the possibility that oligonucleotides creating more complex mismatches are less well recognized by the cell's MMR system and would therefore perform with higher efficiency in wild-type cells. We have designed a series of oligonucleotides that could create a start codon and activate the defective target 2 neo gene by replacing two to five nucleotides simultaneously (Figure 1b) . We found large differences in the performance of these oligonucleotides in wild-type cells and in some cases also in Msh2 À/À cells. Oligos mxm and mxmxm, aimed at correcting the defective start codon in target 2 and creating two and three mismatches, respectively, performed as poorly in wild-type cells as the single mismatch oligo 1m. Also, oligo 3n creating a start codon by substituting three adjacent nucleotides immediately downstream of the mutated start codon in target 2 performed as poorly as oligos 1m, mxm and mxmxm. Remarkably, substitution of one additional nucleotide (oligo 4n) increased the efficiency in wildtype cells approximately 10-fold to a level that was only 20-fold lower than in Msh2 À/À cells (oligos 3n and 4n differ with a P-value of 0.004).
Oligos 2M, 3M, 4M and 5M were designed to create a start codon just upstream of the defected start codon in target 2. However, in this case, increasing the number of mismatches did not significantly improve the oligo targeting frequency in wild-type cells, but led to a marked decrease of targeting frequencies in Msh2
cells. This suggests that the efficacy of oligo targeting is not only influenced by the MMR system but also by other factors operating in Msh2 À/À cells such as the stability of the heteroduplex. It remains possible that these factors have masked an improvement of oligo targeting in wildtype cells by increasing the number of mismatches. Sometimes a three-nucleotide substitution could be obtained with reasonable frequency in wild-type cells. For example, the generation of a new start codon by oligo 3N occurred with a frequency that was significantly above that of oligo 3n (P-value ¼ 0.03) and above oligo 3M with near significance (P-value ¼ 0.09). In this case, the frequency was not further improved by adding an additional mismatch (oligo 4N).
Together, these results demonstrate that the level of suppression of oligo targeting by MMR is determined by the specific mismatches that are created. Although we observed a tendency for larger mismatches to escape to some extent detection by the MMR machinery, these experiments did not reveal a simple numerical rule governing the efficiency of oligo targeting in wild-type cells.
Oligonucleotide-directed base insertion
A start codon in target 2 could also be introduced by insertion of an ATG codon ( Figure 1c ). However, this event was at least 200-fold suppressed by MMR activity. To further investigate the possibility that larger insertions may escape detection by the MMR machinery and can be effectively introduced into wild-type cells, we used target 1 in which the neo open-reading frame was disrupted by a GT frameshift mutation (Figure 2a . Strikingly, we observed that in wild-type cells, insertion of the four-nucleotide sequence ACCA (ssDNA oligo +4-7) was at least 10-fold more effective than insertion of a single A at the same position (P-value ¼ 0.005) and only 26-fold less effective as in Msh2 À/À cells. To further investigate whether the improved efficiency of inserting four nucleotides is a general phenomenon, we designed a series of oligonucleotides varying the position and/or the sequence of the four-nucleotide insertion. Figure 2b shows that positioning of the ACCA insertion one nucleotide to the right (oligo +4-2) reduced the efficiency in wild-type cells, whereas positioning the insertion one nucleotide to the left (oligo +4-3) enhanced the efficiency, leading to a 10-fold difference between oligos +4-3 and +4-2 (P-valueo0.001). Oligo +4-3 was in wildtype cells only 10-fold less effective as in Msh2 À/À cells. Also, varying the sequence of the four-nucleotide insertion at the same position (immediately downstream of the ATG) affected the efficiency in wild-type cells. While oligos +4-3, -1, -5 and -10 performed well in wildtype cells, oligo +4-8 was fivefold less effective than oligo +4-3 (P-valueo0.001), although the latter two were equally effective in Msh2 À/À cells (Figure 2b ). Changing the ACCA insertion in oligo +4-2 for CTAC (oligo +4-4) slightly improved the efficacy in wild-type cells (P-value ¼ 0.05). Finally, we tested four different insertions between the two cytosines of codon 3. Also, these oligonucleotides seemed to perform slightly better than oligo +4-2, although none of the differences reached statistical significance (P-values40.05).
These results demonstrate that in MMR-proficient cells, oligonucleotides inserting four nucleotides generally perform better than the oligonucleotides inserting or deleting one, two or three nucleotides that were tested in this study and before. 15 However, not all four-nucleotide insertions worked equally well in wild-type cells. We therefore conclude that the efficiency of inserting four nucleotides is influenced by the specific sequence of the insertion and its immediate surrounding.
Oligonucleotide-mediated insertion of four nucleotides in Msh3
À/À cells The MSH2/6 dimer has been suggested to recognize single base-base mismatches and small loops of one to Figure 1 Oligonucleotide-mediated base substitution. (a) A single copy of a defective neo gene carrying an A to T point mutation (*) in the start codon was inserted into the Rosa 26 locus of wild-type and Msh2 À/À ES cells as described (15) . (b) neo activity can be restored by singlestranded deoxyribo-oligonucleotides (ssDNA oligo). ssDNA oligonucleotides are indicated in dark blue; nucleotide substitutions giving mismatched base pairs in red. 1m, corrects the startcodon by substituting A for T; mxm, as 1m but substituting an additional nucleotide; mxmxm, as 1m but substituting two additional nucleotides; 3n creates a new startcodon by substituting the second codon for ATG; 4n, as 3n but substituting an additional nucleotide; 2M, creates a new start codon by substituting two nucleotides just upstream of the mutated startcodon; 3M, as 2M but substituting an additional nucleotide; 4M, as 2M but substituting two additional nucleotides; 5M, as 2M but substituting three additional nucleotides; 3N creates a new start codon by substituting the third codon for ATG; 4N, as 3N but substituting an additional nucleotide. The efficiency of oligo targeting in Msh2 À/À and wild-type (WT) ES cells is the number of G418-resistant colonies/10 5 cells that were plated after exposure to the oligonucleotides. Given is the mean of at least three experiments with the standard deviation in brackets. Elevated efficiencies in WT cells are indicated in bold. (c) Oligo +3 restores neo activity by inserting ATG just upstream of the defective start codon.
Oligo targeting in MSH3-deficient ES cells M Dekker et al three unpaired nucleotides, whereas the MSH2/3 heterodimer is believed to predominantly recognize larger loops. We therefore assumed that oligonucleotidemediated insertion/deletion of one or two nucleotides is predominantly suppressed by MSH2/6 activity, whereas insertion of four nucleotides is subject to MSH2/3 recognition. In Msh2 À/À cells, this distinction cannot be made as both activities are abrogated. Therefore, we have introduced the target 1 neo reporter into the Rosa26 locus of Msh3 À/À cells and compared the efficiency of the +1 and +4 oligonucleotides in these cells to their performance in wild-type and Msh2 À/À cells. Figure 2b shows that, as expected, the +1 oligonucleotide performed as poorly in Msh3 À/À cells as in wild-type cells, confirming the specificity of the MSH2/6 complex (which is still present in Msh3
À/À cells, De Wind et al.
22
) for small mismatches. In contrast, all +4 oligonucleotides, except +4-2, significantly improved in Msh3 À/À cells compared to wild-type cells (P-values for oligos +4-7, -3, -1, -5, -10, -4, -9 o0.002; for oligos +4-8, -6, -12 o0.02), in about half of the cases (oligos +4-7, -3, -1, -5, -10 and -4), reaching a frequency that was only two-to threefold lower as in Msh2
À/À cells. The performance of oligos +4-6, -9, -12 and -13 remained three-to sevenfold lower as in Msh2 À/À cells. Oligo +4-8 significantly improved in Msh3 À/À cells, but remained 10-fold less effective as in Msh2 À/À cells. Only oligo +4-2 still performed poorly in Msh3 À/À cells, with a frequency only slightly but not significantly higher than in wild-type cells (P-value ¼ 0.07).
These observations suggest that the mismatch generated by the +4-2 oligonucleotide is strongly recognized 
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by MSH2/6, whereas those formed by +4 oligonucleotides -7, -3, -1, -5, -10 and -4 are predominantly recognized by MSH2/3. The other oligonucleotides, in particular +4-8, seem to be recognized by both complexes. Of twelve +4 oligonucleotides tested, 11 performed with a reasonable efficiency in Msh3-deficient cells.
Oligonucleotide-mediated 4 bp insertion in Fancf
Our results suggest that in Msh3-deficient cells, oligonucleotide-mediated insertion of four nucleotides is generally sufficiently effective to allow disruption of genes without employing a selectable phenotype. As an example, we present here the disruption of the Fanconi anemia gene Fancf. Oligonucleotide sequence Fancf-TAAA was designed to introduce a 4 bp insertion in the Fancf open-reading frame generating a stop codon behind position 277 (Figure 3a) . Msh3 À/À cells were exposed to oligonucleotide Fancf-TAAA and seeded in two 96-well plates at a density of 5000 cells/well. Cells were cultured and each well was split in two. To identify wells containing cells that had undergone the planned modification, DNA was subjected to the PCR protocol described in Figure 3b . First, genomic Fancf DNA surrounding the targeting site was amplified using PCR primers 1 and 2. The 420 bp product was sub- 
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sequently subjected to a mutation-specific PCR using primer pairs 3 and 4 or primer pairs 5 and 6, of which primers 3 and 5 are specific for the TAAA insertion (Figure 3b ). Six wells were identified giving a PCR product using the insertion-specific primer pairs 3, 4 and 5, 6 (examples are shown in Figure 3c ). From one of these wells, the insertion-containing cell was cloned in three rounds in which cells were seeded in 96-wells at densities of 200 and 10 cells and finally 1 cell/well, respectively. The TAAA insertion disrupts the recognition site for the restriction enzymes PpuMI and EcoO109I. This allowed us to confirm the heterozygosity of Fancf in the single-cell clone by Southern blotting (Figure 3d) . Furthermore, sequencing of primer 1, 2 products revealed a 1:1 ratio of wild-type and mutant sequence demonstrating successful insertion of TAAA (Figure 3e ).
Discussion
We have previously shown that oligo targeting in mouse ES cells is strongly suppressed by DNA MMR activity. 15 As different base-base mismatches are recognized and repaired by the MMR machinery with different efficiencies, it is likely that the level of suppression of oligo targeting depends on the type of mismatch. 23 Indeed, in the E. coli/Redb system, an oligonucleotide generating a C-C mismatch performed with high efficiency in wild-type cells consistent with the poor repair of C-C mismatches by the E. coli mutS,L,H MMR system. 16, 24 Here, we demonstrate that in mammalian cells, certain compound alterations and four-nucleotide insertions are poorly detected by the MMR system and can be introduced in MMR-proficient cells. Moreover, we show that in general four-nucleotide insertions can be effectively introduced in cells lacking the MSH3 branch of MMR.
Base substitution
Our initial results with the m and n oligonucleotides (Figure 1b) suggested that oligonucleotide-mediated substitution of one to three nucleotides was strongly suppressed by MSH2 activity. Addition of one extra base substitution increased the efficiency of oligo targeting 10-fold, suggesting that four mismatches on a row are less well recognized by the MMR machinery than smaller substitutions. However, this is certainly not a general phenomenon. For example, the efficiency of another three-nucleotide modification (oligo 3N) was clearly above background level, but was not further enhanced upon addition of an extra base substitution (compare 3N and 4N in Figure 1b) . Moreover, in another series of oligonucleotides, addition of base substitutions did not enhance the oligo targeting efficiency in wild-type cells at all (M oligonucleotides in Figure 1b) . It should be noted that in this series, the efficiency in Msh2 À/À cells decreased with an increasing number of mismatches. Perhaps, the heteroduplex formed by the oligonucleotide and its chromosomal complement became increasingly destabilized. This may have masked an improvement of more complex substitutions in wild-type cells.
These results show that the use of oligonucleotides generating compound mismatches can be a viable approach to improve the efficacy of oligo targeting in wild-type cells. However, the available data do not yet allow derivation of general rules for the design of oligonucleotides that can effectively mediate base substitutions in the presence of MMR activity.
Base insertion
A much clearer picture emerged from experiments on oligonucleotide-mediated base insertion: we found that in MMR-proficient cells, four-nucleotide insertion oligonucleotides performed better than a single-nucleotide insertion oligonucleotide (Figure 2b) . However, also here, considerable variations were observed between different +4 oligonucleotides. Oligo +4-2 performed just above background level, whereas oligos +4-1 and +4-3 were at least 40-fold more effective than the +1 oligonucleotide, reaching a level that was only 10-fold lower than in Msh2 À/À cells. Comparing the performance of 12 different +4 oligonucleotides indicated that the sequence and location of the insert strongly impacts on the targeting efficiency in MMR-proficient cells.
In eukaryotes, unpaired loops of two to five nucleotides in DNA are recognized by the MSH2/3 mismatch recognition complex rather than by MSH2/6. We therefore studied the performance of +4 oligonucleotides in Msh3 À/À cells. Based on their performance in wild-type and Msh3
À/À cells, these oligonucleotides can be grouped in four classes (Table 1) À/À cells. II Oligos +4-7, -4, -6, -9, -12 and -13 performed poorly to moderately in MMR-proficient cells but showed a sixto 14-fold increase in Msh3 À/À cells. (Table 1) : Class I oligos +4-3, -1, -5 and -10 are weakly recognized by MSH2/3 and poorly by MSH2/6; Class II oligos +4-7, -4, -6, -9, -12 and -13 are well recognized by MH2/3 and poorly to weakly by MSH2/6; Class III oligo +4-8 is weakly recognized by MSH2/3 and moderately by MSH2/6; and Class IV oligo +4-2 is strongly recognized by MSH2/6 and presumably also by MSH2/3.
Rules for four-nucleotide insertion in Msh3
À/À cells
Our results indicate that the activity of +4 oligonucleotides in Msh3 À/À cells strongly depends on the exact sequence context of the modification. We envisage that the most decisive factor is whether this context can generate a mismatch that is recognized by the MSH2/6 complex: effective modifications are only poorly to weakly recognized by the MSH2/6 complex. This appeared to be the case for 10 of the twelve +4 oligonucleotides that were tested. In principle, it is possible to use in vitro assays to monitor the binding capacity of purified MSH2/6 protein complex to mismatch-containing double-stranded oligonucleotides. We are currently performing such assays with the expectation that they have predictive value for the efficacy of oligo targeting. Should this be the case, such assays may become a routine in the practice of oligo targeting.
Evidently, it would be more desirable to find general rules that obviate the need for experimentation. Is it possible to predict whether a four-nucleotide insertion will be recognized by MSH2/6? One would expect all +4 oligonucleotides hybridizing to their chromosomal complement to generate a four-nucleotide extrahelical loop that is supposed to be exclusively targeted by MSH2/3 complex. To explain recognition of certain insertions by MSH2/6, we envisage that besides these looped structures, alternative base pairing is possible and that the level of suppression of oligo targeting by MSH2/6 depends on the chance that these alternative structures arise and the capacity of MSH2/6 to recognize them. Of the five oligonucleotides that have the insert placed immediately downstream of the start codon between the two G residues, four are poorly recognized by MSH2/6. Indeed, it is difficult to envisage alternative base pairing for oligo +4-3 and +4-10 and alternative structures for +4-1 and +4-5 require disruption of two G-C base pairs and are apparently not very favorable (Figure 4) . However, oligo +4-8 may readily adopt the alternative conformation shown in Figure 4 , which could explain suppression of the +4-8 insertion by MSH2/6 activity. An alternative structure for oligo +4-2 does not seem very favorable; Figure 4 Mismatch recognition by MSH2/3 and MSH2/6: influenced by the sequence context? Alternative base pairing of four-nucleotide insertions may lead to recognition by MSH2/6 and suppression of oligo targeting. For oligo +4-1, alternative base pairing is less likely and the four-nucleotide insertion is mainly recognized by MSH2/3. Oligo +4-2 may readily adopt the alternative structure and is efficiently recognized by MSH2/6. Also oligo +4-8 may adopt a structure that is recognized by MSH2/6, although this is less likely than for oligo +4-2.
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however, based on the poor performance of this oligonucleotide in Msh3 À/À cells, we assume that this or a similar structure can be formed and efficiently be recognized by MSH2/6 ( Figure 4 ). It should be noted here that the interaction with the MMR proteins might favor alternative structures that seem at first glance less likely. For example, upon binding to bacterial MutS, a looped-out T was forced into a G-T mispair at the expense of an extrahelical C. 25 From these results and considerations, we have tentatively derived a simple rule to achieve effective oligonucleotide-mediated four-nucleotide insertions in Msh3 À/À cells: the four nucleotide sequence must not be capable of forming base pairs with the complementary strand, including relatively stable mismatches such as G-T. Also placing the insert between G-C base pairs may help to favor the extrahelical structure. Following this rule, insertion of four nucleotides in Msh3 À/À cells generally occurs with an efficiency above 5/10 6 cells. This is sufficiently high to identify and purify modified cells using specific PCR protocols as we have demonstrated here for oligonucleotide-mediated disruption of the Fancf gene. Importantly, as Msh3 À/À ES cells have no overt mutator phenotype and Msh3-deficient mice are not cancer prone, we believe that these cells may become the routine target cell for oligonucleotide-mediated gene disruption. 22 However, more experimentation will be required to identify general rules for oligonucleotidemediated base substitution.
Materials and methods
Wild-type and Msh2
À/À ES cells carrying a single copy of the target 1 or target 2 neo reporter genes have been described. 15 Similarly, we introduced target 1 into Msh3 À/À ES cells. 22 Non-chemically modified deoxyribonucleotides were obtained from Sigma-Genosys Ltd. Procedures for introducing oligonucleotides in ES cells, selection for G418-resistant colonies and identification and purification of modified cells by PCR were essentially as described before. 15 Briefly, Msh2 À/À cells (7 Â 10 5 on 10 cm 2 ), wild-type and Msh3 À/À cells (21 Â 10 5 on 30 cm 2 ) were grown overnight and exposed to TransFastt (27 or 81 ml) plus oligonucleotide (3 or 9 mg) in 1.4 ml serum-free medium/10 cm 2 for 1 h. After addition of 4 ml serum-containing medium, cells were grown overnight. Subsequently, cells were trypsinized, counted and plated on 10 cm Petri dishes in the presence of 600 mg/ml (target 1) or 750 mg/ml (target 2) of G418. The frequency of oligo targeting (the number of G418-resistant colonies per number of cells plated) was calculated as the mean of at least three independent experiments. Statistical significance of differences between different oligonucleotides in the same cell line or the same oligonucleotide in different cell lines was assessed by calculating P-values using Student's t-test.
For Southern blot analysis, DNA from Msh3 À/À ES cells and Msh3 À/À ES cells containing the planned modification in Fancf, was digested with PpuMI or EcoO109I (New England Biolabs) and run on agarose gels. DNA was transferred to a Hybond-N + filter and hybridized to a radioactively labelled probe consisting of a 400 bp SmaI-BstX I fragment of genomic Fancf.
